PU.1转录因子和辅助性Th9细胞与变应性鼻炎

doi:10.6040/j.issn.1673-3770.0.2018.456

摘要/Abstract

摘要：

变应性鼻炎AR是IgE介导的鼻黏膜的I型变态反应性疾病，既往对AR的认识已由Th1/Th2型细胞因子的不平衡扩展为Th1/Th2/Th17/Treg细胞模式。而近年发现的Th9细胞在变态反应性疾病的发生发展中发挥着重要作用。PU.1是Ets(E26 transformation specific)家族中重要的转录因子，在机体天然免疫、获得性免疫的调节有着重要作用。PU.1的激活则直接影响Th9细胞的发育分化调节及生物学特性。主要总结转录因子PU.1和Th9细胞在变应性鼻炎发病机制中的可能作用。

关键词: 变应性鼻炎, 辅助性T细胞9, 转录因子PU.1, 白细胞介素9

Abstract:

Allergic rhinitis is an IgE-mediated type I allergic disease of the nasal mucosa. Previous knowledge of AR has been extended from the imbalance of Th1/Th2 type cytokines to the Th1/Th2/Th17/Treg cell pattern. The Th9 cells discovered in recent years play an important role in the occurrence and development of allergic diseases. PU.1 is an important transcription factor in the Ets family and plays an important role in the regulation of natural immunity and acquired immunity. The activation of PU.1 directly affects the developmental differentiation and biological characteristics of Th9 cells. This article summarizes the possible roles of transcription factors PU.1 and Th9 cells in the pathogenesis of allergic rhinitis.

Key words: Allergic rhinitis, Helper T cell 9, Transcription factor PU.1, Interleukin-9

中图分类号:

R765.21

刘小涵,张小兵. PU.1转录因子和辅助性Th9细胞与变应性鼻炎[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 139-143.

Xiaohan LIU,Xiaobing ZHANG. PU.1 transcription factor and helper Th9 cells with allergic rhinitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 139-143.

参考文献 39

1	程雷, 钱俊俊, 田慧琴 . 变应性鼻炎研究的若干进展[J]. 山东大学耳鼻喉眼学报, 2017, 31(3): 1-3. doi:10.6040/j.issn.1673-3770.1.2017.021 . doi: 10.6040/j.issn.1673-3770.1.2017.021
	CHENG Lei , QIAN Junjun , TIAN Huiqin . Research progresses on allergic rhinitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2017, 31(3): 1-3. doi:10.6040/j.issn.1673-3770.1.2017.021 . doi: 10.6040/j.issn.1673-3770.1.2017.021
2	Schlapbach C , Gehad A , Yang C , et al . Human TH₉ cells are skin-tropic and have autocrine and paracrine proinflammatory capacity[J]. Sci Transl Med, 2014, 6(219): 219. doi:10.1126/scitranslmed.3007828 . doi: 10.1126/scitranslmed.3007828
3	Koh B , Hufford MM , Sun X , et al . Etv5 regulates IL-10 production in Th cells[J]. J Immunol, 2017, 198(5):2165-2171. doi: 10.4049/jimmunol.1600801 . doi: 10.4049/jimmunol.1600801
4	Uyttenhove C , Simpson RJ , van Snick J . Functional and structural characterization of P₄₀, a mouse glycoprotein with T-cell growth factor activity.[J]. Proceedings of the National Academy of Sciences, 1988, 85(18): 6934-6938. doi:10.1073/pnas.85.18.6934 . doi: 10.1073/pnas.85.18.6934
5	Temann UA , Ray P , Flavell RA . Pulmonary overexpression of IL-9 induces Th₂ cytokine expression, leading to immune pathology[J]. J Clin Invest, 2002, 109(1): 29-39. doi:10.1172/JCI13696 . doi: 10.1172/JCI13696
6	Veldhoen M , Uyttenhove C , van Snick J , et al . Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset[J]. Nat Immunol, 2008, 9(12): 1341-1346. doi:10.1038/ni.1659 . doi: 10.1038/ni.1659
7	Dardalhon V , Awasthi A , Kwon H , et al . IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells[J]. Nat Immunol, 2008, 9(12): 1347-1355. doi:10.1038/ni.1677 . doi: 10.1038/ni.1677
8	Ma CS , Tangye SG , Deenick EK . Human Th₉ cells: inflammatory cytokines modulate IL-9 production through the induction of IL-21[J]. Immunol Cell Biol, 2010, 88(6): 621-623. doi:10.1038/icb.2010.73 . doi: 10.1038/icb.2010.73
9	Liao W , Spolski R , Li P , et al . Opposing actions of IL-2 and IL-21 on Th₉ differentiation correlate with their differential regulation of BCL6 expression[J]. Proc Natl Acad Sci USA, 2014, 111(9): 3508-3513. doi:10.1073/pnas.1301138111 . doi: 10.1073/pnas.1301138111
10	Angkasekwinai P , Sodthawon W , Jeerawattanawart S , et al . ILC₂s activated by IL-25 promote antigen-specific Th₂ and Th₉ functions that contribute to the control of Trichinella spiralis infection[J]. PLoS One, 2017, 12(9): e0184684. doi:10.1371/journal.pone.0184684 . doi: 10.1371/journal.pone.0184684
11	Chen JT , Zhao YH , Chu X , et al . Dectin-1-activated dendritic cells: A potent Th₉ cell inducer for tumor immunotherapy[J]. Oncoimmunology, 2016, 5(11): e1238558. doi:10.1080/2162402X.2016.1238558 . doi: 10.1080/2162402X.2016.1238558
12	Froidure A , Shen C , Gras D , et al . Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th₂ and Th₉ responses[J]. Allergy, 2014, 69(8): 1068-1076. doi:10.1111/all.12435 . doi: 10.1111/all.12435
13	Bi EG , Ma XZ , Lu Y , et al . Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of T_H9 cells programmed by IL-7[J]. Sci Signal, 2017, 10(500): eaak9741. doi:10.1126/scisignal.aak9741 . doi: 10.1126/scisignal.aak9741
14	Murugaiyan G , Beynon V , Pires da Cunha A , et al . IFN- limits Th₉-mediated autoimmune inflammation through dendritic cell modulation of IL-27[J]. The Journal of Immunology, 2012, 189(11): 5277-5283. doi:10.4049/jimmunol.1200808 . doi: 10.4049/jimmunol.1200808
15	Richard AC , Tan CY , Hawley ET , et al . Correction: the TNF-family ligand TL1A and its receptor DR3 promote t cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing t cells[J]. J Immunol, 2015, 195(12): 5839-5840. doi:10.4049/jimmunol.1502026 . doi: 10.4049/jimmunol.1502026
16	Xiao X , Balasubramanian S , Liu WT , et al . OX40 signaling favors the induction of T(H)₉ cells and airway inflammation[J]. Nat Immunol, 2012, 13(10): 981-990. doi:10.1038/ni.2390 . doi: 10.1038/ni.2390
17	Kerzerho J , Maazi H , Speak AO, et al . Programmed cell death ligand 2 regulates TH₉ differentiation and induction of chronic airway hyperreactivity[J]. J Allergy Clin Immunol, 2013, 131(4): 1048-1057, 1057.e1-2. doi: 10.1016/j.jaci.2012.09.027 . doi: 10.1016/j.jaci.2012.09.027
18	Li H , Edin ML , Bradbury JA , et al . Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB[J]. Am J Respir Crit Care Med, 2013, 187(8): 812-822. doi:10.1164/rccm.201211-2073OC . doi: 10.1164/rccm.201211-2073OC
19	Ahmad SF , Nadeem A , Ansari MA, et al . Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2017, 79(Pt B): 472-480. doi:10.1016/j.pnpbp.2017.08.002 . doi: 10.1016/j.pnpbp.2017.08.002
20	Vegran F , Martin F , Apetoh L , et al . Th₉ cells: a new population of helper T cells[J]. Med Sci (Paris), 2016, 32(4): 387-393. doi:10.1051/medsci/20163204017 . doi: 10.1051/medsci/20163204017
21	Végran F , Berger H , Boidot R , et al . The transcription factor IRF₁ dictates the IL-21-dependent anticancer functions of TH₉ cells[J]. Nat Immunol, 2014, 15(8): 758-766. doi:10.1038/ni.2925 . doi: 10.1038/ni.2925
22	Rampal R , Awasthi A , Ahuja V . Retinoic acid-primed human dendritic cells inhibit Th9 cells and induce Th1/Th17 cell differentiation[J]. J Leukoc Biol，2016，100(1):111-1120. doi: 10.1189/jlb.3VMA1015-476R . doi: 10.1189/jlb.3VMA1015-476R
23	Hoppenot D , Malakauskas K , Lavinskiene S , et al . p-STAT6, PU.1, and NF-κB are involved in allergen-induced late-phase airway inflammation in asthma patients[J]. BMC Pulm Med, 2015, 15: 122. doi:10.1186/s12890-015-0119-7 . doi: 10.1186/s12890-015-0119-7
24	Gomez-Rodriguez J , Meylan F , Handon R , et al . Itk is required for Th₉ differentiation via TCR-mediated induction of IL-2 and IRF₄ [J]. Nat Commun, 2016, 7: 10857. doi:10.1038/ncomms10857 . doi: 10.1038/ncomms10857
25	Jabeen R . Retroviral transduction and reporter assay: transcription factor cooperation in Th₉ cell development[J]. Methods Mol Biol, 2017, 1585: 155-166. doi:10.1007/978-1-4939-6877-0_12 . doi: 10.1007/978-1-4939-6877-0_12
26	Koch S , Graser A , Mirzakhani H , et al . Increased expression of nuclear factor of activated T cells 1 drives IL-9–mediated allergic asthma[J]. Journal of Allergy and Clinical Immunology, 2016, 137(6): 1898-1902.e7. doi:10.1016/j.jaci.2015.11.047 . doi: 10.1016/j.jaci.2015.11.047
27	Chang HC , Sehra S , Goswami R , et al . The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation[J]. Nat Immunol, 2010, 11(6): 527-534. doi:10.1038/ni.1867 . doi: 10.1038/ni.1867
28	Mohapatra A , Van Dyken SJ , Schneider C , et al . Group 2 innate lymphoid cells utilize the IRF₄-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis[J]. Mucosal Immunol, 2016, 9(1): 275-286. doi:10.1038/mi.2015.59 . doi: 10.1038/mi.2015.59
29	Sehra S , Yao WG , Nguyen ET , et al . TH₉ cells are required for tissue mast cell accumulation during allergic inflammation[J]. J Allergy Clin Immunol, 2015, 136(2): 433-440.e1. doi:10.1016/j.jaci.2015.01.021 . doi: 10.1016/j.jaci.2015.01.021
30	Yashiro T , Kubo M , Ogawa H , et al . PU.1 suppresses Th₂ cytokine expression via silencing of GATA3 transcription in dendritic cells[J]. PLoS One, 2015, 10(9): e0137699. doi:10.1371/journal.pone.0137699 . doi: 10.1371/journal.pone.0137699
31	Ueno N , Nishimura N , Ueno S , et al . PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF₄ [J]. Oncogene, 2017, 36(31): 4481-4497. doi:10.1038/onc.2017.79 . doi: 10.1038/onc.2017.79
32	Awe O , Hufford MM , Wu H , et al . PU.1 expression in t follicular helper cells limits CD40L-dependent germinal center b cell development[J]. J Immunol, 2015, 195(8): 3705-3715. doi:10.4049/jimmunol.1500780 . doi: 10.4049/jimmunol.1500780
33	Gerlach K , Hwang Y , Nikolaev A , et al . TH₉ cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells[J]. Nat Immunol, 2014, 15(7): 676-686. doi:10.1038/ni.2920 . doi: 10.1038/ni.2920
34	Koh B , Hufford MM , Pham D , et al . The ETS family transcription factors etv5 and PU.1 function in parallel to promote Th₉ cell development[J]. J Immunol, 2016, 197(6): 2465-2472. doi:10.4049/jimmunol.1502383 . doi: 10.4049/jimmunol.1502383
35	Nouri-Aria KT , Pilette C , Jacobson MR , et al . IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy[J]. J Allergy Clin Immunol, 2005, 116(1): 73-79. doi:10.1016/j.jaci. 2005.03.011 . doi: 10.1016/j.jaci. 2005.03.011
36	Devos S , Cormont F , Vrtala S , et al . Allergen-induced interleukin-9 production in vitro: correlation with atopy in human adults and comparison with interleukin-5 and interleukin-13[J]. Clin Exp Allergy, 2006, 36(2): 174-182. doi:10.1111/j.1365-2222.2006.02422.x . doi: 10.1111/j.1365-2222.2006.02422.x
37	Ciprandi G , De Amici M , Castellazzi AM , et al . Serum IL-9 levels depend on allergen exposure: preliminary study[J]. Int Arch Allergy Immunol, 2011, 154(3): 246-248. doi:10.1159/000321111 . doi: 10.1159/000321111
38	Gu ZW , Wang YX , Cao ZW . Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th₂, Th₉, and Th₁₇ responses and increasing the Treg response in a murine model[J]. Oncotarget, 2017, 8(9): 14314-14324. doi:10.18632/oncotarget.15177 . doi: 10.18632/oncotarget.15177
39	Sehra S , Yao WG , Nguyen ET , et al . Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation[J]. J Immunol, 2011,186(8):4959-4966. doi: 10.4049/jimmunol.1002359 . doi: 10.4049/jimmunol.1002359

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

[1]	吕倩,唐源,顾子君,施赛磊,刘萍,万文锦. 变应性鼻炎患者疾病获益感现状及影响因素分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 21-28.
[2]	顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111.
[3]	秦娜娜,李玉芬,孙雨浩,魏健,李钦. 基于TGF-β1/Smad信号通路探讨白细胞介素13受体α2对变应性鼻炎大鼠鼻黏膜组织重塑的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 71-77.
[4]	熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[5]	许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[6]	刘怡君,谷悦,官大宇,杨玉成,沈暘. 翼管神经切断术在难治性变应性鼻炎中远期临床疗效和安全性[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 42-48.
[7]	张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147.
[8]	张竹萍,彭孜灿,肖振龙,李程,喻迪,王兴龙,陈伟,郭蓓. 新型鼻分泌物嗜酸粒细胞阳离子蛋白-髓过氧化物酶试纸在变应性鼻炎中的应用价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 129-134.
[9]	刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58.
[10]	周荷青,申琪. 中医药治疗变应性鼻炎疗效的生物标志物研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 168-176.
[11]	王曼娴,郑泉,杨亮. 细菌裂解物治疗变应性鼻炎的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 141-145.
[12]	刘畅,方宏艳,刘敩,富东娜,王贺,王晶,杨景朴. 长春地区秋季变应性鼻炎蒿属花粉致敏特征分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 13-19.
[13]	朱朗,刘志奇. 移动医疗提供的真实世界数据在变应性鼻炎治疗方案中的参考[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 135-139.
[14]	张静祎,董湘依,牟亚魁,宋西成. 细胞焦亡在耳鼻咽喉科疾病中的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 140-148.
[15]	张丽净,冯晓星,刘南仙,赵辉明,陈月华. 石墨烯养护鼻罩结合尘螨的皮下特异性免疫治疗在尘螨变应性鼻炎患者中的应用分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 26-32.